CVS Health Total Liabilities 2012-2025 | CVS
CVS Health total liabilities from 2012 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- CVS Health total liabilities for the quarter ending September 30, 2025 were $182.217B, a 2.76% increase year-over-year.
- CVS Health total liabilities for 2024 were $177.485B, a 2.54% increase from 2023.
- CVS Health total liabilities for 2023 were $173.092B, a 10.6% increase from 2022.
- CVS Health total liabilities for 2022 were $156.506B, a 0.71% decline from 2021.
|
CVS Health Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $177,485 |
| 2023 | $173,092 |
| 2022 | $156,506 |
| 2021 | $157,618 |
| 2020 | $161,014 |
| 2019 | $158,279 |
| 2018 | $137,913 |
| 2017 | $57,436 |
| 2016 | $57,628 |
| 2015 | $55,234 |
| 2014 | $36,224 |
| 2013 | $33,588 |
| 2012 | $28,568 |
| 2011 | $26,492 |
|
CVS Health Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-09-30 | $182,217 |
| 2025-06-30 | $180,792 |
| 2025-03-31 | $178,475 |
| 2024-12-31 | $177,485 |
| 2024-09-30 | $177,321 |
| 2024-06-30 | $177,370 |
| 2024-03-31 | $175,593 |
| 2023-12-31 | $173,092 |
| 2023-09-30 | $176,796 |
| 2023-06-30 | $177,069 |
| 2023-03-31 | $167,750 |
| 2022-12-31 | $156,506 |
| 2022-09-30 | $160,201 |
| 2022-06-30 | $154,773 |
| 2022-03-31 | $158,733 |
| 2021-12-31 | $157,618 |
| 2021-09-30 | $160,273 |
| 2021-06-30 | $157,599 |
| 2021-03-31 | $158,442 |
| 2020-12-31 | $161,014 |
| 2020-09-30 | $163,786 |
| 2020-06-30 | $167,140 |
| 2020-03-31 | $165,165 |
| 2019-12-31 | $158,279 |
| 2019-09-30 | $157,180 |
| 2019-06-30 | $157,305 |
| 2019-03-31 | $159,762 |
| 2018-12-31 | $137,913 |
| 2018-09-30 | $94,884 |
| 2018-06-30 | $97,679 |
| 2018-03-31 | $96,462 |
| 2017-12-31 | $57,436 |
| 2017-09-30 | $57,985 |
| 2017-06-30 | $58,378 |
| 2017-03-31 | $58,828 |
| 2016-12-31 | $57,628 |
| 2016-09-30 | $58,202 |
| 2016-06-30 | $57,982 |
| 2016-03-31 | $56,603 |
| 2015-12-31 | $55,234 |
| 2015-09-30 | $55,182 |
| 2015-06-30 | $37,535 |
| 2015-03-31 | $36,935 |
| 2014-12-31 | $36,224 |
| 2014-09-30 | $35,467 |
| 2014-06-30 | $34,461 |
| 2014-03-31 | $34,610 |
| 2013-12-31 | $33,588 |
| 2013-09-30 | $29,271 |
| 2013-06-30 | $27,378 |
| 2013-03-31 | $27,859 |
| 2012-12-31 | $28,568 |
| 2012-09-30 | $27,880 |
| 2012-06-30 | $27,676 |
| 2012-03-31 | $27,953 |
| 2011-12-31 | $26,492 |
| 2011-09-30 | $27,764 |
| 2011-06-30 | $27,243 |
| 2011-03-31 | $24,909 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $99.777B | $372.809B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $166.692B | 30.61 |
| HCA Healthcare (HCA) | United States | $107.089B | 17.73 |
| Elevance Health (ELV) | United States | $83.311B | 12.22 |
| Cencora (COR) | United States | $68.838B | 22.19 |
| Natera (NTRA) | United States | $31.987B | 0.00 |
| DiDi Global (DIDIY) | China | $23.485B | 21.70 |
| Labcorp Holdings (LH) | United States | $22.455B | 17.12 |
| Medpace Holdings (MEDP) | United States | $17.208B | 42.72 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.445B | 0.00 |
| Viatris (VTRS) | United States | $14.812B | 5.52 |
| BioMerieux (BMXMF) | France | $14.802B | 0.00 |
| ICON (ICLR) | Ireland | $14.747B | 14.63 |
| Solventum (SOLV) | United States | $13.786B | 13.38 |
| Revvity (RVTY) | United States | $12.755B | 23.49 |
| CochLear (CHEOY) | Australia | $11.760B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.813B | 20.82 |
| Avantor (AVTR) | United States | $8.291B | 12.67 |
| Sonic Healthcare (SKHHY) | Australia | $7.752B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.556B | 0.00 |
| HealthEquity (HQY) | United States | $7.294B | 27.27 |
| BrightSpring Health Services (BTSG) | United States | $7.070B | 42.15 |
| Bausch + Lomb (BLCO) | Canada | $6.078B | 39.91 |
| PACS (PACS) | United States | $6.072B | 36.92 |
| Sotera Health (SHC) | United States | $5.449B | 26.27 |
| Alignment Healthcare (ALHC) | United States | $4.502B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.124B | 54.86 |
| Concentras Parent (CON) | United States | $2.762B | 17.24 |
| Organon (OGN) | United States | $2.277B | 2.40 |
| Progyny (PGNY) | United States | $2.114B | 41.56 |
| Surgery Partners (SGRY) | United States | $2.057B | 26.50 |
| Establishment Labs Holdings (ESTA) | United States | $1.962B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.877B | 11.21 |
| Ardent Health (ARDT) | United States | $1.231B | 4.02 |
| Teladoc Health (TDOC) | United States | $1.115B | 0.00 |
| Nutex Health (NUTX) | United States | $1.080B | 8.26 |
| CareDx (CDNA) | United States | $1.029B | 16.82 |
| Omada Health (OMDA) | United States | $0.933B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.910B | 14.89 |
| InnovAge Holding (INNV) | United States | $0.794B | 0.00 |
| Embecta (EMBC) | United States | $0.734B | 4.17 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.706B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.594B | 0.00 |
| CryoPort (CYRX) | United States | $0.552B | 0.00 |
| Enhabit (EHAB) | United States | $0.532B | 23.91 |
| Strata Critical Medical (SRTA) | United States | $0.515B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.445B | 8.19 |
| Agilon Health (AGL) | United States | $0.423B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.343B | 5.51 |
| Oncology Institute (TOI) | United States | $0.330B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.288B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.279B | 58.75 |
| So-Young (SY) | China | $0.269B | 0.00 |
| KindlyMD (NAKA) | United States | $0.201B | 0.00 |
| Beauty Health (SKIN) | United States | $0.191B | 0.00 |
| LifeMD (LFMD) | United States | $0.181B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.141B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.139B | 0.00 |
| DocGo (DCGO) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.046B | 0.00 |
| Pomdoctor - (POM) | China | $0.030B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.21 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.018B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.016B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |